The Beatrice Hunter Cancer Research Institute logo
  • Dr. David Hoskin, PhD

Appointments:

Professor, Departments of Pathology, Microbiology & Immunology and Surgery
Affiliated Scientist, Department of Pathology and Laboratory Medicine, Capital Health
Canadian Breast Cancer Foundation-Atlantic Region Endowed Chair in Breast Cancer Research

Affiliations:

Dalhousie University Faculty of Medicine, Capital Health

Research Interests:

Anti-cancer potential of natural-source compounds, including cationic antimicrobial peptides and phytochemicals found in common spices; manipulation of T lymphocyte signal transduction for cancer control

Exploring the cancer-fighting potential of food and spice derivatives

Dr. David Hoskin has found that a fragment of milk protein known as lactoferricin triggers the death of cancer cells obtained from a wide range of human malignancies, including breast, colon and ovarian tumours and various leukemias and lymphomas. He is working on methods to deliver lactoferricin and other anti-cancer peptides directly to cancer cells. Dr. Hoskin is also investigating the anti-cancer activity of molecules found in common spices like turmeric and black pepper.

Involvement with BHCRI to date:

Dr. Hoskin is a BHCRI Senior Scientist, has served on the BHCRI Working Group, BHCRI Development Board, CRTP Management Committee, BHCRI Training Committee and has been a supervisor for CRTP trainees.

Phone:

(902) 494-6509

Contact:

Sir Charles Tupper Medical Building, Dalhousie University Faculty of Medicine, 5850 College Street, P.O. Box 15000, Halifax, Nova Scotia, Canada B3H 4R2
Site by: Spectacle Group